MC Riddle - Endocrinology and metabolism clinics of North America, 2005 - Elsevier We have long known, but now understand more fully that type 2 diabetes is
common, complex, and as treated presently, leads to severe medical consequences.
In type 1 diabetes, hyperglycemia is the leading cause of harm. In type 2 ... Cited by 67 - Related articles - All 3 versions
- Free from Publisher J Rosenstock, DR Hassman, RD Madder, SA … - Diabetes Care, 2004 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—Enrolled patients (n = 150) had received treatment
with diet and exercise in the previous 3 months with HbA 1c >7 and ≤12%.
Patients were randomized to receive monotherapy with repaglinide (n = 76) ... Cited by 60 - Related articles - BL Direct - All 6 versions
SM Setter, JL Iltz, J Thams, RK Campbell - Clinical therapeutics, 2003 - Elsevier Results: Metformin is the only currently available oral
antidiabetic/hypoglycemic agent that acts predominantly by inhibiting hepatic
glucose release. Because patients with type 2 diabetes often have excess ... Cited by 47 - Related articles - All 3 versions
KR Sargrad, C Homko, M Mozzoli, G Boden - Journal of the American Dietetic Association, 2005 - Elsevier Study patients were admitted to the General Clinical Research Center for 24
hours for initial tests including a hyperinsulinemic-euglycemic clamp (for
measurement of insulin sensitivity), bioelectrical impedance analysis (BIA) ... Cited by 46 - Related articles - All 14 versions
S Roze, WJ Valentine, KE Zakrzewska, AJ … - Diabetic Medicine, 2005 - interscience.wiley.com Methods The CORE Diabetes Model is a peer-reviewed, validated model which
employs standard Markov/Monte Carlo simulation techniques to describe the
long-term incidence and progression of diabetes-related complications. It ... Cited by 42 - Related articles - BL Direct - All 5 versions
MO Goodarzi, M Bryer-Ash - Diabetes Obesity and Metabolism, 2005 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 28 - Related articles - BL Direct - All 4 versions
JF Blickle - Diabetes and Metabolism, 2006 - Elsevier Glinides represent a chemically heterogeneous new class of insulinsecreting
agents characterized by a rapid onset and short duration of action. They act by
closure of the ATP-dependant K channel. Repaglinide, the only glinide ... Cited by 16 - Related articles - BL Direct - All 3 versions
- ►peoriaendocrine.com [PDF] SR Chipkin - The American journal of medicine, 2005 - Elsevier The increased number of oral agents available to treat patients with type 2
diabetes mellitus (DM) has presented clinicians with choices about how to
combine them when monotherapy is not adequate to achieve glycemic targets. ... Cited by 12 - Related articles - All 8 versions
